2,003
Views
15
CrossRef citations to date
0
Altmetric
ARTICLES

Suboxone Misuse Along the Opiate Maintenance Treatment Pathway

Pages 53-67 | Published online: 12 Mar 2013
 

Abstract

This study explores strategies that Suboxone misusers utilize while in drug treatment. Ethnographic interviews were conducted with 14 patients who had cycled in and out of Suboxone treatment. The objective of the study is to identify strategies implemented by patients who intermittently use opiates/opioids while in Suboxone treatment. Findings indicate that some patients serially stop and start treatment in a Harm Reduction setting in New York City. Many patients suggest that they manage their opiate/opioid dependency through a sequential use of Suboxone and heroin to avoid withdrawal and to continue their misuse of opiates/opioids. Results are discussed in conjunction with the difficulties inherent to substance abuse treatment and suggestions for improvement are offered.

Notes

1. From herein, instead of the opiate/opioids designation, the phrase illicit drug(s) will be used, except when opiate is used in an historical or appropriate context. It also should be noted that the harm reduction approach to drug treatment does not explicitly forbid or encourage illicit drug use.

2. I’d like to thank Dr. Ross Coomber, PhD, of Plymouth University, UK, for directing me to this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.